GlassScriptPhysician profile
Oksana Richards
NPI 1629473897
$8,074.22
in general payments reported to CMS, 2019-2025
26 companies · $959 in 2025
The $959 reported for 2025 was more than what 82% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $2,850 · 2022: $859 · 2023: $2,032 · 2024: $1,374 · 2025: $959.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,279 · Travel and Lodging: $1,494 · Education: $592.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,278.91 |
| Travel and Lodging | $1,493.82 |
| Education | $591.97 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arthrex, INC. | $2,834.00 | 2021 | |
| Boston Scientific Corporation | $1,666.35 | 2024-2025 | Intracept, General - Pain Management, Wavewriter Alpha Prime 16 |
| Nevro Corp. | $1,404.59 | 2023-2024 | Senza |
| Medtronic, INC. | $271.67 | 2023-2025 | Intellis Adaptivestim, Inceptiv, Synchromedii |
| Boehringer Ingelheim Pharmaceuticals, INC. | $238.76 | 2022-2023 | Ofev |
| Takeda Pharmaceuticals U.S.A., INC. | $213.29 | 2022-2023 | Glassia |
| Saluda Medical Americas, INC. | $212.62 | 2025 | Evoke |
| Astrazeneca Pharmaceuticals LP | $167.85 | 2022-2023 | Breztri, Fasenra |
| Abbott Laboratories | $166.17 | 2023 | Eterna |
| Jazz Pharmaceuticals INC. | $134.61 | 2022-2023 | |
| Globus Medical, INC. | $93.09 | 2025 | Vyrsa V1, Senza |
| Stryker Corporation | $87.01 | 2025 | Mild Device Kit |
| Grifols USA, LLC | $78.19 | 2022-2023 | Prolastin-C Liquid |
| Amgen INC. | $76.29 | 2022 | |
| Abbvie INC. | $66.10 | 2024 |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Baxter Healthcare | $56.79 | 2022-2023 | Hillrom - Life 2000 Ventilation System |
| Spr Therapeutics, INC | $49.68 | 2024-2025 | Sprint Pns System |
| Si-Bone, INC. | $43.87 | 2024 | |
| Glaxosmithkline, LLC. | $43.19 | 2022-2023 | Nucala |
| Harmony Biosciences LLC | $42.34 | 2022 | |
| Genzyme Corporation | $37.63 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $22.73 | 2022 | |
| Electromed, INC. | $19.24 | 2022 | |
| Teva Pharmaceuticals USA, INC. | $18.68 | 2022 | |
| Zimmer Biomet Holdings, INC. | $16.16 | 2021 | |
| Inogen, INC. | $13.32 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Oksana Richards listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.